36 related articles for article (PubMed ID: 2737758)
1. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
Kaye KS; Cosgrove S; Harris A; Eliopoulos GM; Carmeli Y
Antimicrob Agents Chemother; 2001 Sep; 45(9):2628-30. PubMed ID: 11502540
[TBL] [Abstract][Full Text] [Related]
2. Biochemical profiles and serotypes of nosocomial Enterobacter cloacae strains in Northern Norway: biochemical identification problems with commercial test systems.
Andersen BM
Infection; 1995; 23(6):339-43. PubMed ID: 8655203
[TBL] [Abstract][Full Text] [Related]
3. The cephalosporin compounds in severe neonatal infection.
Schaad UB
Eur J Pediatr; 1984 Jan; 141(3):143-6. PubMed ID: 6321189
[TBL] [Abstract][Full Text] [Related]
4. Enterobacter: an emerging nosocomial pathogen.
Gaston MA
J Hosp Infect; 1988 Apr; 11(3):197-208. PubMed ID: 2899104
[No Abstract] [Full Text] [Related]
5. Septicaemia caused by an Enterobacter cloacae strain varying in resistance against cephalosporins.
Andersen BM; Dahl IM; George RC; Gilfillian A
Infection; 1989; 17(3):156-9. PubMed ID: 2737758
[TBL] [Abstract][Full Text] [Related]
6. [Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
Nauciel C; Philippon A; Ronco E; Pilliot J; Guenounou M; Paul G; Brunel D; Outin HD
Presse Med; 1985 Mar; 14(12):673-6. PubMed ID: 3157961
[TBL] [Abstract][Full Text] [Related]
7. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit.
Modi N; Damjanovic V; Cooke RW
Arch Dis Child; 1987 Feb; 62(2):148-51. PubMed ID: 3827292
[TBL] [Abstract][Full Text] [Related]
8. The emergence of resistance and the therapy of septicaemia.
Phillips I; Shannon K
Chemioterapia; 1985 Feb; 4(1):90-4. PubMed ID: 3986947
[TBL] [Abstract][Full Text] [Related]
9. Multiply beta-lactam resistant Enterobacter cloacae infections linked to the environmental flora in a unit for cardiothoracic and vascular surgery.
Andersen BM; Sørlie D; Hotvedt R; Almdahl SM; Olafsen K; George R; Gilfillian A
Scand J Infect Dis; 1989; 21(2):181-91. PubMed ID: 2727635
[TBL] [Abstract][Full Text] [Related]
10. Cefpirome (HR 810): lack of selection of beta-lactamase overproducing variants.
Cullmann W; Dick W
J Antibiot (Tokyo); 1985 Jul; 38(7):912-9. PubMed ID: 3875601
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia.
Kurrle E; Bhaduri S; Krieger D; Gaus W; Heimpel H; Pflieger H; Arnold R; Vanek E
J Infect Dis; 1981 Aug; 144(2):128-36. PubMed ID: 7276625
[TBL] [Abstract][Full Text] [Related]
12. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.
Gootz TD; Sanders CC; Goering RV
J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593
[TBL] [Abstract][Full Text] [Related]
13. Patterns of oropharyngeal and fecal flora in patients with acute leukemia.
Fainstein V; Rodriguez V; Turck M; Hermann G; Rosenbaum B; Bodey GP
J Infect Dis; 1981 Jul; 144(1):10-8. PubMed ID: 6790630
[TBL] [Abstract][Full Text] [Related]
14. Development of resistance to cephalosporins in clinical strains of Citrobacter spp.
Gootz TD; Jackson DB; Sherris JC
Antimicrob Agents Chemother; 1984 May; 25(5):591-5. PubMed ID: 6610388
[TBL] [Abstract][Full Text] [Related]
15. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance.
Olson B; Weinstein RA; Nathan C; Kabins SA
J Antimicrob Chemother; 1983 Apr; 11(4):299-310. PubMed ID: 6602122
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
